Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2022

View Archived Issues

NBL-028: a CLDN6-CD137 bispecific antibody for treating CLDN6-positive tumors

QL-401 shows improved blood safety and is efficacious against solid and hematologic cancers

ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models

Metacrine divulges new HSD17B13 inhibitors

RaQualia Pharma patents CRF2 receptor antagonists

LYL-797, ROR1-targeted CAR T-cell candidate designed using reprogramming technologies

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

Cullgen identifies new PROTACs

AstraZeneca presents new PROTACs for cancer

ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace

NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers

Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study

Virpax reports preclinical PK results for VRP-324 for management of seizures

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

CIDRAP receives funding to create coronavirus vaccines R&D roadmap

WVE-004 shows promise for treating C9orf72-associated neurologic disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...